Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Allergan Sales, LLC
EIR
•Allergan Sales, LLC•January 22, 2019

Allergan Sales, LLC – FDA EIR, Jan 22, 2019

Record Details

An FDA inspection of Allergan plc's Irvine, CA facility was conducted from January 14-22, 2019, focusing on the company's responsibilities as a sponsor of a pivotal clinical investigation. While no formal FDA 483 inspectional observations were issued, the inspection highlighted several significant discussion items. Key issues identified included deficiencies in financial disclosure and annual reporting. Specifically, ten clinical investigators received substantial consulting payments from Allergan but failed to promptly update their financial disclosure forms or notify the sponsor and Institutional Review Board (IRB). Additionally, Allergan’s 2018 annual report to the FDA omitted protocol deviations related to three serious adverse events that were not reported within the required timeframe. The company's 2017 annual report was also submitted 22 days past its due date, as stipulated by their Investigational Device Exemption (IDE) approval. Allergan management acknowledged these points. They committed to following up with investigators to ensure accurate financial disclosures and stated that corrections would be made to the data listing and reflected in the clinical study report for the omitted serious adverse event deviations. The inspection emphasized the importance of timely and accurate reporting and disclosure in accordance with regulatory expectations for clinical studies.

Company
Allergan Sales, LLC
Inspection date
January 22, 2019
Product type
devices
Office
Los Angeles District Office
People
  • Naduka K. Amaratunge (company_representative)
  • Elaina Hontalas (company_representative)
  • Cody Braswell (company_representative)
  • Mary Lou Moore (company_representative)
  • Ann M. Hegarty (company_representative)
View Company Profile

ID · 2d27d1f8-96e5-449e-99a5-31ae7ee72003

Violation Codes2
21 CFR 820.3021 CFR 820.100

Full citation text and observation details available on the Dashboard.

Other documents for Allergan Sales, LLC
  • 483 - 2025-11-07November 7, 2025
  • EIR - 2013-12-23December 23, 2013
  • 483 - 2010-07-09July 9, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Allergan Sales, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.